Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches, a hormone replacement therapy (HRT) product, which were due to expire on 10 July 2026, have been extended until Friday 2 October 2026. 

This Circular advises Health Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for ramipril 1.25mg capsules remains in place following an extension to its expiry date. 

A Serious Shortage Protocol is in place for ramipril 1.25mg capsules from 22 April to 29 May 2026. Guidance for community pharmacies.

UK-wide Serious Shortage Protocols for Estradot® patches and Creon® capsules extended to 10 July 2026. Guidance for community pharmacies.

A new national PGD for oral candidiasis is being added to NHS Pharmacy First Scotland. Guidance for Health Boards and community pharmacy teams.

Scottish Government circular announcing a new Patient Group Direction for skin inflammation within NHS Pharmacy First Scotland.

UK‑wide Serious Shortage Protocols for Estradot patches and Creon 10000 capsules extended to 17 April 2026. Details for pharmacists included.

SSP withdrawal for Adipine® XL modified-release tablets, and Fixapost® preservative-free eye drops, originally due to expire on 6 February 2026, will now be withdrawn early 

SSP extensions for Creon 10000 and 25000 have been issued. Pharmacists must review new end dates and continue limiting supply to one month.